Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
The increasing prevalence of diabetes and its complications, such as cardiovascular and kidney disease, remains a huge burden globally. Identification of biomarkers for the screening, diagnosis, and prognosis of diabetes and its complications and better understanding of the molecular pathways involv...
Guardado en:
Autores principales: | Qiao Jin, Ronald Ching Wan Ma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4a76a2341924835850b0ef95b4d7521 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus
por: Chunyu Zhou, et al.
Publicado: (2021) -
Serum integrative omics reveals the landscape of human diabetic kidney disease
por: Shijia Liu, et al.
Publicado: (2021) -
Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016)
por: Minara S. Shamkhalova, et al.
Publicado: (2018) -
In situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease
por: Bai Linnan, et al.
Publicado: (2021) -
UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats
por: Heyu Wang, et al.
Publicado: (2021)